Results 191 to 200 of about 38,480 (291)

Weighing the evidence: apixaban for pediatric leukemia. [PDF]

Blood Adv
Raffini L, Whitworth H.
europepmc   +1 more source

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial. [PDF]

Europace
Lamy A, Sandhu RK, Tong W, McIntyre WF, Lopes RD, Granger CB, Wright DJ, Nielsen JC, Nielsen JC, Kutyifa V, Erath JW, Alings M, Birnie DH, Atar D, Hohnloser SH, Linde C, Kautzner J, Benezet-Mazuecos J, Camm AJ, Sticherling C, Gold MR, Larroudé CE, Healey JS.   +22 more
europepmc   +1 more source

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban [PDF]

, 2016
Kenechukwu Mezue, Chukwudi Obiagwu, Jinu John, Abhishek Sharma, Felix Yang, Jacob Shani   +5 more
openalex   +1 more source

Apixaban reduces risk of thromboembolism [PDF]

Nature Reviews Clinical Oncology, 2018
openaire   +3 more sources

In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments. [PDF]

Drug Des Devel Ther
Du W, Liu Z, Li Y, Wang Z, Dong Z.
europepmc   +1 more source

Blood to the Bone: Epistaxis Leading to Osteomyelitis. [PDF]

Case Rep Med
Kazi Z, Zou B, Boadla MR, Chapnick E.
europepmc   +1 more source

Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban [PDF]

, 2016
Waltraud Pfeilschifter, Thurid Steinstraesser, Patrick Paulus, Pia S. Zeiner, Ferdinand O. Bohmann, A. Theisen, Edelgard Lindhoff‐Last, Cornelia Penski, Marlies Wagner, Michel Mittelbronn, Christian Foerch   +10 more
openalex   +1 more source

Appropriate dosing of apixaban [PDF]

Nature Reviews Cardiology, 2016
openaire   +2 more sources

Assess the reporting quality of randomized controlled clinical trials exploring the efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation based on CONCORT statement [PDF]

, 2016
Μαντζουράτου, Πολυξένη Δ.
core   +1 more source